BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33983712)

  • 1. NAD(P)H Quinone Oxidoreductase-1 in Organ and Tumor Tissues: Distinct Activity Levels Observed with a Benzo-rosol-Based Dual-Excitation and Dual-Emission Probe.
    Yang YJ; Dai M; Reo YJ; Song CW; Sarkar S; Ahn KH
    Anal Chem; 2021 May; 93(20):7523-7531. PubMed ID: 33983712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-contrast NIR fluorescent probes for selective detection of NQO1 in breast cancer.
    Liu H; Hu F; Cao Z; Qu Y; Wen H; Wang X; Li W
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Apr; 311():123898. PubMed ID: 38340443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-ratiometric fluorescence sensing and real-time detection of HOCl and NQO1 using a single fluorescent probe under one-wavelength excitation.
    Yue X; Yang Y; Lan M; Li K; Wang B
    Anal Chim Acta; 2022 Sep; 1224():340242. PubMed ID: 35998994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.
    Zhang K; Chen D; Ma K; Wu X; Hao H; Jiang S
    J Med Chem; 2018 Aug; 61(16):6983-7003. PubMed ID: 29712428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing Push-Pull Hydroxylphenylpolyenylpyridinium Chromophores as Ratiometric Two-Photon Fluorescent Probes for Cellular and Intravital Imaging of Mitochondrial NQO1.
    Yang YP; Qi FJ; Qian YP; Bao XZ; Zhang HC; Ma B; Dai F; Zhang SX; Zhou B
    Anal Chem; 2021 Feb; 93(4):2385-2393. PubMed ID: 33439630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4.
    Shaw PM; Reiss A; Adesnik M; Nebert DW; Schembri J; Jaiswal AK
    Eur J Biochem; 1991 Jan; 195(1):171-6. PubMed ID: 1899380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1) Activatable Salicylamide H
    Roy NJ; Save SN; Sharma VK; Abraham B; Kuttanamkuzhi A; Sharma S; Lahiri M; Talukdar P
    Chemistry; 2023 Sep; 29(51):e202301412. PubMed ID: 37345998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues.
    Belinsky M; Jaiswal AK
    Cancer Metastasis Rev; 1993 Jun; 12(2):103-17. PubMed ID: 8375015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.
    Punganuru SR; Madala HR; Arutla V; Zhang R; Srivenugopal KS
    Sci Rep; 2019 Jun; 9(1):8577. PubMed ID: 31189950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation.
    Bian J; Li X; Xu L; Wang N; Qian X; You Q; Zhang X
    Eur J Med Chem; 2017 Feb; 127():828-839. PubMed ID: 27829520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
    Jaiswal AK; Burnett P; Adesnik M; McBride OW
    Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
    Dehn DL; Winski SL; Ross D
    Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An NAD(P)H:Quinone Oxidoreductase 1 Responsive and Self-Immolative Prodrug of 5-Fluorouracil for Safe and Effective Cancer Therapy.
    Zhang X; Li X; Li Z; Wu X; Wu Y; You Q; Zhang X
    Org Lett; 2018 Jun; 20(12):3635-3638. PubMed ID: 29847952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of NQO1 responsive fluorescence probe and its application in bio-imaging for cancer diagnosis.
    Yuan Z; Xu M; Wu T; Zhang X; Shen Y; Ernest U; Gui L; Wang F; He Q; Chen H
    Talanta; 2019 Jun; 198():323-329. PubMed ID: 30876568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.
    Winski SL; Swann E; Hargreaves RH; Dehn DL; Butler J; Moody CJ; Ross D
    Biochem Pharmacol; 2001 Jun; 61(12):1509-16. PubMed ID: 11377380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis.
    Long DJ; Waikel RL; Wang XJ; Perlaky L; Roop DR; Jaiswal AK
    Cancer Res; 2000 Nov; 60(21):5913-5. PubMed ID: 11085502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL; Hargreaves RH; Butler J; Ross D
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
    Joseph P; Jaiswal AK
    Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.